Matthew L. Trerotola - 14 May 2021 Form 4 Insider Report for Colfax CORP (ENOV)

Role: President & CEO, Director
Signature: /s/ Bradley Tandy, Attorney-in-Fact
Issuer symbol: ENOV
Transactions as of: 14 May 2021
Net transactions value: -$3,880,400
Form type: 4
Filing time: 17 May 2021, 20:00:32 UTC
Next filing: 23 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENOV	Common stock, par value $.001	Options Exercise	$4,748,000	+200,000	+65%	$23.74	505,708	14 May 2021	Direct
transaction	ENOV	Common stock, par value $.001	Sale	$8,628,400	-200,000	-40%	$43.14	305,708	14 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENOV	Employee stock option (right to buy)	Options Exercise	$0	-200,000	-36%	$0.000000	359,563	14 May 2021	Common stock, par value $.001	200,000	$23.74	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.89 to $43.18, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
F2	The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 1/4/2016.

Content

The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.89 to $43.18, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 1/4/2016.